Overview

Coagulation Analyzer LMCA-A401 offers 2×16 sample positions to maximize throughput efficiently. Equipped with dual-channel system, it delivers faster and simultaneous coagulation testing. Incorporated with long-life LED beam source for reliable photo-optical detection and stability. It features back-illuminated LCD display and membrane keypad for seamless operation and navigation. Our Coagulation Analyzer with built-in incubator maintains stable temperature for consistent results.

Features :

Automatic stirring system

Seven-point calibration

User-friendly software

Low reagent consumption

In-built thermal printer

Large memory capacity

Specifications :

Channels	Dual channel
Test Parameters	PT (prothrombin time), APTT (Activated Partial Thromboplastin Time), TT (Thrombin Time), FBG (Fibrinogen), Clotting Factors (time/ratio/INR)
Sample Positions	16 positions
Reagent Positions	4 positions
Reagent Consumption	50 to 100µl
Temperature	37 °C ±0.3 °C
Principle	Scattering methods
Beam Source	Long-life LED
Cuvette Measuring	Magnetic Stirring Motor
Data input	Membrane keypad
Display	Back-illuminated LCD
Power Supply	AC110V, 60Hz/220V, 50Hz
Dimensions	370 × 370 × 120 mm
Weight	8 kg

Optional Accessories :

Model No	Accessory
LMCA-A401-P1	Prothrombin Time PT (Reagent: 2ml×10, Buffer: 30ml×1)
LMCA-A401-A1	Activate Partial Thromboplastin Time APTT (Reagent: 2ml×10, CaCl2: 30ml×1)
LMCA-A401-T1	Thrombin Time TT (Reagent: 2ml×10, Buffer: 30ml×1)
LMCA-A401-F1	Fibrinogen FIB (Reagent: 2ml×2, Buffer: 5ml×1, Diluent: 30ml×4/1ml×1)

Applications :

Coagulation Analyzer LMCA-A401 is ideal for routine PT, APTT, TT, and fibrinogen testing in hospitals, diagnostic laboratories, and blood banks. It is widely employed in pre-surgical screening, monitoring anticoagulant therapy, and evaluating clotting disorders.

Selection Guide :

Coagulation Analyzer LMCA-A401 is a two-channel analyzer designed for accurate assessment of blood clotting functions in clinical, research, and diagnostic laboratories. It supports essential coagulation tests, including PT, APTT, TT, and Fbg, making it suitable for studies involving coagulation pathways and anticoagulant monitoring. The device evaluates both exogenous and endogenous pathways, providing results in activation percentages (A%), ratios, and INR values for standardized reporting. Using a double magnetic route test method provides high accuracy and reliability in time-sensitive experiments. Customers should select this model for applications requiring certified performance, versatile test parameters, and dependable results in clinical diagnostics and hematology research.